Gain-of-Function Research

Gain-of-function research involves genetic modifications that enhance pathogen characteristics such as transmissibility, virulence, or host range. Scientists conduct this research to understand pandemic risks and develop countermeasures, but critics argue it creates dangerous pathogens that could cause catastrophic outbreaks if released accidentally or intentionally.

The controversy intensified after laboratory accidents in the early 2000s and high-profile incidents involving anthrax, SARS, and H5N1 influenza at CDC and other facilities. The U.S. implemented a moratorium on certain GoF research from 2014-2017 before developing new oversight frameworks under the HHS P3CO (Potential Pandemic Pathogen Care and Oversight) guidelines.

Research conducted at the Wuhan Institute of Virology, some funded by U.S. grants through EcoHealth Alliance, became central to COVID-19 origin debates. Scientists Peter Daszak and Ralph Baric collaborated on coronavirus research that some classify as gain-of-function, though definitions remain disputed among experts and policymakers.

Proponents argue GoF research provides essential knowledge for pandemic preparedness and vaccine development. Critics contend the risks outweigh benefits, advocating for alternative research approaches that don't create enhanced pathogens. The debate reflects broader tensions between scientific freedom, public safety, and national security considerations in virology research.